Oasys and occupational asthma banner logo

Vancomycin manufacture, a new cause of OA acting by direct histamine release?

Vancomycin manufacture, a new cause of OA acting by direct histamine release?

A pharmacetical worker who developed occupational asthma and rhinitis 5 months after starting purification of vancomycin powder. Positive peak flow and history, refused specific challenge. IgE and skin prick testing to vancomycin negative, but strong basophil histamine release using HSA conjugate (negative in controls). Authors suggest that the mechanism is direct histamine release

Agent Vancomycin
Job Pharmaceutical manufacturer
Specific IgE negative
Skin prick test negative
Non-specific reactivity methacholine 0.933 mg/ml
Serial Peak Flow positive  (9.3-62% variablility on workdays, <10% on days off)
 BAL not done
 FENO not done
Basophil histamine release Significant histamine relase from patients basophils with 1ug/ml HSA conjugate, no release from controls. Authors  suggest mechanism is direct non-allergic histamine release
Specific Challenge 

Refused

Follow-up

no information

References

Abstract Available for A case of occupational asthma caused by inhalation of vancomycin powder Choi G-S, Sung J-M, Lee J-W, Ye Y-M, Park H-S, A case of occupational asthma caused by inhalation of vancomycin powder, Allergy, 2009;64:1391-1392,
Hae-Sim Park, Korea, an author of 'A case of occupational asthma caused by inhalation of vancomycin powder'

Comments

Please sign in or register to add your thoughts.


Oasys and occupational asthma smoke logo